Pesquisas alternativas:
drug classes » drug class (Expandir a Pesquisa)
drug losses » drag losses (Expandir a Pesquisa), drug doses (Expandir a Pesquisa), drug houses (Expandir a Pesquisa)
derived tnf » derived tgf (Expandir a Pesquisa)
does devel » does level (Expandir a Pesquisa), does deep (Expandir a Pesquisa), does novel (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
drug classes » drug class (Expandir a Pesquisa)
drug losses » drag losses (Expandir a Pesquisa), drug doses (Expandir a Pesquisa), drug houses (Expandir a Pesquisa)
derived tnf » derived tgf (Expandir a Pesquisa)
does devel » does level (Expandir a Pesquisa), does deep (Expandir a Pesquisa), does novel (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
1
Por Pollastri, Michael P., Whitty, Adrian, Merrill, Jamie Cassidy, Ashton, Trent D., Amar, Salomon
Publicado em 2009
“...There is a substantial unmet need for new classes of drugs that block TNF-α-mediated inflammation...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“... are constantly under pressure, higher percentages of drugs are demanded, and the drug-discovery process is a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
4
Por Shreya Gopalakrishnan, Shreya Gopalakrishnan, Marianne Doré Hansen, Marianne Doré Hansen, Helene Kolstad Skovdahl, Helene Kolstad Skovdahl, Ingrid Aass Roseth, Atle van Beelen Granlund, Atle van Beelen Granlund, Atle van Beelen Granlund, Ann Elisabet Østvik, Ann Elisabet Østvik, Ingunn Bakke, Ingunn Bakke, Arne Kristian Sandvik, Arne Kristian Sandvik, Arne Kristian Sandvik, Torunn Bruland, Torunn Bruland
Publicado em 2022-05-01
Assuntos:
“...tumor necrosis factor (TNF)...”Publicado em 2022-05-01
Obter o texto integral
Artigo
5
“..., this study aimed to evaluate the pharmacokinetic (PK) interactions between these two drugs in healthy males...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Dondossola, Eleonora, Dobroff, Andrey S., Marchiò, Serena, Cardó-Vila, Marina, Hosoya, Hitomi, Libutti, Steven K., Corti, Angelo, Sidman, Richard L., Arap, Wadih, Pasqualini, Renata
Publicado no Proc Natl Acad Sci U S A (2016)
“... potentially using patient-derived circulating tumor cells as self-targeted vectors for drug delivery....”Publicado no Proc Natl Acad Sci U S A (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose
Publicado no Drug Des Devel Ther (2017)
“... of the administered drug and the duration of the administration itself. Triggers for postconditioning...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Fallon, Padraic G.
Publicado em 2009
“... -- The Immunosuppresive Tick Salivary Protein, Salpl5 -- The Serpin Saga; Development of a New Class of Virus Derived Anti...”Publicado em 2009
Obter o texto integral
Livro
9
10
Por Benjamin J Andrick, Alexandra I Schwab, Brianna Cauley, Lauren A O'Donnell, Wilson S Meng
Publicado em 2015-01-01
“... of patients with rheumatoid arthritis (RA) develop anti-drug antibodies towards anti-TNFα biologics. We...”Publicado em 2015-01-01
Obter o texto integral
Artigo
11
Por Andrick, Benjamin J., Schwab, Alexandra I., Cauley, Brianna, O’Donnell, Lauren A., Meng, Wilson S.
Publicado no PLoS One (2015)
“... of patients with rheumatoid arthritis (RA) develop anti-drug antibodies towards anti-TNFα biologics. We...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Gahr, Maximilian, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Lepping, Peter, Freudenmann, Roland W
Publicado em 2011
“... pharmacological profile, including single dosing, predominantly renal excretion, low drug–drug interaction risk...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Li, Dejun, Ji, Hongsheng, Zhao, Bao, Xu, Chunyang, Xia, Wenjun, Han, Lihui, Yu, Dongqing, Ju, Yuanrong, Jin, Changjun
Publicado no Mol Med Rep (2018)
“... necrosis and dysplasia of interstitial fibrotic tissue, resulting in loss of lung function and eventual...”Publicado no Mol Med Rep (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Daugherty, Daniel J., Marquez, Alexandra, Calcutt, Nigel A., Schubert, David
Publicado no Neuropharmacology (2017)
“... hypoxia, inflammation and loss of neurotrophic support. The curcumin derivative J147 is a potent...”Publicado no Neuropharmacology (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Schepetkin, Igor A., Kirpotina, Liliya N., Khlebnikov, Andrei I., Hanks, Tracey S., Kochetkova, Irina, Pascual, David W., Jutila, Mark A., Quinn, Mark T.
Publicado em 2012
“... unique series of tetracyclic indenoquinoxaline derivatives that inhibited lipopolysaccharide (LPS...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
17
18
Por Genovese, Mark C, Fleischmann, Roy, Furst, Daniel, Janssen, Namieta, Carter, John, Dasgupta, Bhaskar, Bryson, Judy, Duncan, Benjamin, Zhu, Wei, Pitzalis, Costantino, Durez, Patrick, Kretsos, Kosmas
Publicado em 2014
“... with the safety profile expected of this class of drug, with no new safety signals identified. TRIAL REGISTER...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Ge, Xingtao, Chen, Zhijian, Xu, Zhenjie, Lv, Fang, Zhang, Kewei, Yang, Yu
Publicado no Exp Biol Med (Maywood) (2018)
“... observed the effects of dihydroartemisinin (DHA), an antimalaria drug, on IBD and IBD-induced bone loss...”Publicado no Exp Biol Med (Maywood) (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“... condition that usually responds to this class of drug. A wide range of PAEs have been reported including...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo